A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

VirtaMed and Medical Microinstruments Partner to Advance the Skills of Surgeons Performing Complex Robotic Microsurgeries

VirtaMed’s VR simulations provide advanced training for surgeons using MMI’s Symani® Robotic System and introduce new product testing capabilities

VirtaMed, a world leader in medical simulation training, and Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, have announced a partnership where surgeons using MMI’s Symani® Surgical System will have access to groundbreaking surgical simulations, leading to advanced skill development and robotic system enhancements.

Microsurgeries are a category of complex surgical procedures that focus on reconstructive surgery and require optical magnification, precision, and dexterity. VirtaMed is developing custom surgical simulations for the Symani System that include aspects of virtual reality (VR) and allow surgeons to train on the system itself. These VR-enabled simulations will allow surgeons to practice a variety of microsurgeries using the Symani robotic system and simulated surgical scenarios.

This will provide MMI and surgeons with a range of benefits including the ability to improve and measure surgical skills in a safe, simulated environment, and access to data-driven insights into surgical approaches that can be used to make enhancements to the Symani System. As robotic microsurgeries continue to grow, opportunities for advanced product development and training are essential to improve patient safety and outcomes.

“Surgeon confidence and patient safety are essential to successful outcomes. This belief has guided our product and partnership approach since the company was formed,” said Stefan Tuchschmid, Co-CEO at VirtaMed. “Our team is excited to partner with MMI, whose microinstruments truly expand human capabilities in microsurgery. By offering surgeons the opportunity to use simulations to practice these highly complex surgeries, we create an environment of continual improvement with a focus on patient care.”

The Symani Surgical System is the only robotic platform dedicated to microsurgery that offers wristed microinstruments designed to improve a surgeon’s ability to suture delicate anatomy, which can be difficult to access. The system combines NanoWrist® Instruments, featuring the world’s smallest robotic wrist, with NanoScale® Technology to scale movements and reduce tremor to push the boundaries of micro and supermicrosurgery. Together, these innovations are intended to increase dexterity and precision, reduce complications and reinterventions, and decrease the learning curve for performing complex microsurgical tasks.

In addition, the integration of VirtaMed simulations into the Symani development process will allow MMI to repeatedly and efficiently test new features and solutions that will optimize the product life cycle.

“We were looking for a portable solution that demonstrates the experience and advantages of Symani while providing a realistic microsurgery training environment,” said Mark Toland, CEO of MMI SpA. “In VirtaMed, we’ve found a partner who shares our mission to improve patient outcomes and the quality

of care through comprehensive training methods, allowing us to enrich the training experiences of our surgeons and drive adoption of robotic microsurgery.”

For more on VirtaMed’s robotic training solutions, visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy